Dodatne informacije

• Lični podaci

• Datum rođenja: 03.07.1983. godine
• Mesto rođenja: Leskovac

• Obrazovanje

• Fakultet: Medicinski fakultet
• Odsek / Grupa / Smer: Farmacija
• Godina diplomiranja: 2007.

• Spisak publikacija

• Knjige i udžbenici:
  
  
  1. Nikola Stefanović, Ivana Damnjanović. Priručnik iz farmakoterapije - pregled odabranih slučajeva iz prakse. Medicinski fakultet Niš, Niš, 2021.
  
  
  2. Ivana Nešić, Ivana Damnjanović, Nikola Stefanović. Osnovi savremene farmaceutske prakse. Urednik: Ivana Nešić, Medicinski fakultet Niš, Niš, 2021.
  
  
  3. Radmila Veličković-Radovanović, Aleksandra Catić-Đorđević, Ivana Damnjanović, Nikola Stefanović. Priručnik iz farmakokinetike. Urednik: Radmila Veličković-Radovanović, Medicinski fakultet Niš, Niš, 2015.
  
  
  4. Radmila Veličković-Radovanović, Aleksandra Catić-Đorđević, Ivana Damnjanović (saradnik), Nikola Stefanović (saradnik). Farmakoepidemiologija. Urednik: Radmila Veličković-Radovanović, Medicinski fakultet Niš, Niš, 2014.
  
  
• Radovi u časopisima sa IMPACT faktorom:
  
  
  1. Veličković-Radovanović R, Stefanović N, Damnjanović I, Kocić B, Mladenović-Antić S, Dinić M, Petrović J, Mitić R, Catić-Đorđević A. Eur J Hosp Pharm 2022; 29:84–89. (M23, IF:1.652)
  
  
  2. Catić-Đorđević A, Pavlović I, Spasić A, Stefanović N, Pavlović D, Damnjanović I, Mitić B, Veličković-Radovanović R. Assessment of pharmacokinetic mycophenolic acid clearance models using Monte Carlo numerical analysis. Xenobiotica 2021; 51(4):387-393. (M23, IF: 1.902)
  
  
  3. Stefanović N, Veličković-Radovanović R, Danković K, Catić-Djordjević A, Damnjanović I, Mitić B, Cvetković M, Cvetković T. Insight into the potential influence of inter- and intra-individual variability of tacrolimus exposure on graft function decline in three-year period following kidney transplantation. Farmacia 2020; 68(6):1036-1046. (M23, IF: 1,607).
  
  
  4. Damnjanovic I, Stefanovic N, Zlatkovic-Guberinic S, Damnjanovic Z, Catic-Djordjevic A, Velickovic-Radovanovic R. Self-medication practices among the patients with chronic venous disease. Farmacia 2020; 68(2): 225-231. M23 (IF: 1,607).
  
  
  5. Damnjanovic I, Kocic G, Najman S, Stojanovic S,Tomovic K, Ilic B ,Veljkovic A, Pesic S, Smelcerovic A. Possible molecular mechanisms and pathways involved in BH3 mimetic activity of alpha-lipoic acid on human colon cancer cell line. Farmacia 2019;  67( 2): 226-234. (M23, IF: 1,507).
  
  
  6. Damnjanovic I, Kitic D, Stefanovic N, Velickovic-Radovanovic R. Reply to Letter to the Editor: Herbal self-medication use in Type 2 diabetes mellitus. Turk J Med Sci 2016; 46: 1275-1276. (Научна критика и полемика - M26, IF:0.325, 5-IF:0.372 )
  
  
  7. Velickovic-Radovanovic R, Stefanovic N, Damnjanovic I, Kocic B, Antic S, Dinic M, Petrovic J, Mitic R,  Catic-Djordjevic A. Monitoring of antibiotic consumption and development of resistance by enterobacteria in a tertiary care hospital. J Clin Pharm Ther 2015; 40 (4): 426-430. (M23, IF:1.833, 5-IF:1.804)
  
  
  8. Damnjanovic I, Kitic D, Stefanovic N, Zlatkovic - Guberinic S, Catic - Djordjevic A, Velickovic - Radovanovic R. Herbal self - medication use in patients with diabetes mellitus type 2. Turk J Med Sci 2015; 45: 964-971. (M23, IF: 0.841, 5-IF:0.633)
  
  
  9. Damnjanovic I, Najman S, Stojanovic S, Stojanovic D, Veljkovic A, Kocic H, Langerholc T, Damnjanovic Z, Pesic S. Crosstalk between possible cytostatic and antiinflammatory potential of ketoprofen in the treatment of culture of colon and cervix cancer cell lines. Bratisl Lek Listy. Bratisl Lek Listy 2015; 116(4): 227-232. (M23, IF: 0.439, 5-IF:0.406)
  
  
  10. Damnjanovic I,  Kocic G, Najman S, Stojanovic S, Stojanovic D, Veljkovic A, Conic I, Langerholc T, Pesic S. Chemopreventive potential of alpha lipoic acid in the treatment of culture of colon and cervix cancer cell lines. Bratisl Lek Listy 2014; 115 (10): 610-616. (M23, IF: 0.446, 5-IF:0.463)
  
  
  11. Damnjanovic Z, Jovanovic M, Nagorni A, Radojkovic M, Sokolovic D, Damnjanovic G, Djindjic B, Smiljkovic I, Kamenov A, Damnjanovic I.  Povezanost inflamatornih parametara i biohemijskih markera holestaze sa intenzitetom lipidne peroksidacij kod bolesnika sa holedoholitijazom.Vojnosanit  Pregl 2013; 70(2): 170-176. (M23, IF: 0.210.)
  
  
  12. Conic I, Miljkovic S, Tošic-Golubovic S, Stanojevic Z, Milenkovic D, Djordevic B, Damnjanovic I, Visnjic M, Antic S, Stefanovic V. Anxiety levels related to type of terapy for cervical cancer. Central European Journal of  Medicine 2012; 7(4): 490-496. (M23, IF: 0.262, 5-IF:0.265)
  
  
  13. Damnjanovic Z, Jovanovic M, Bogdanovic D, Smiljkovic I, Ilic N, Damnjanovic I. Relationship between the incidence of idiopathic lower extremity deep vein thrombosis and the location of the thrombus with changesof atmospheric pressure. Chirurgia (Bucur) 2012; 107(4): 483-487.  (M23, IF: 0.777)
  
  
  14. Kocic G, Pavlovic V, Saranac Lj, Kocic R, Zivic S, Sokolovic D, Jevtovic T, Nikolic G, Stojanovic S, Damnjanovic I. Circulating nucleic acids in type 1 diabetes may modulate the thymocyte turnover rate. Cell immunol 2010; 266(1): 76-82. (M23, IF: 2.575, 5-IF:2.333)
  
  
• Radovi u ostalim časopisima:
  
  
  1. Stojanovic S, Damnjanovic I, Najdanovic J, Dzopalic T, Najman S. In vitro analysis of the biological activity of royal jelly on different cell lines. Hrana i ishrana 2021; 62(2): 1-6.
  
  
  2. Krstić N, Kostić I, Petronijević A, Damnjanović I. The influence of therapeutic modalities on the functional ability of patients with rheumatoid arthritis. Acta Medica Medianae 2021; 60(4): 63-71.
  
  
  3. Catić Djordjević A, Stefanović N, Spasić A, Damnjanović I, VeličkovićRadovanović R, Djindjić B, Pavlović D. current overview of COVID-19 vaccination process in Serbia. Actamedica Medianae 2021; 60(3): 20-29.
  
  
  4. Veljković A, Hadzi-Djokic J, Stanojevic G, Brankovic B, Skakic A, Damnjanović I, Stojanovic M, Šmelcerović A,   Kocić G. The importance of urate pathway enzymes activity and its relation with oxidative stress in progression and invazion of human colorectal cancer. Acta Medica Medianae 2021;60(2):05-14.
  
  
  5. Koraćević M, Catić-Djordjević A, Stefanović N, Damnjanović I, Stošić I, Veličković-Radovanović R. The justification of clinical pharmacy skills and knowledge for modern community pharmacist. Acta Medica Medianae 2020; 59(1):14-22.
  
  
  6. Catic – Dordevic A, Stefanovic N, Stosic I, Damnjanovic  I, Milanovic I, Bojanic N, Velickovic – Radovanovic R. Application of the STOPP/ START criteria in the survey of medication use in elderly patients with renal failure. Arch Balk Med Union. 2019; 53(4):685-691.
  
  
  7. Stefanović N, Cvetković T, Dinić K, Mitić B, Paunović G, Damnjanović I, Catić-Đorđević A, Veličković-Radovanović R. Influence of Different Formulations of  Tacrolimus on Dosage Regimen and Drug Exposure Within the First Year After Kidney Transplantation. Hospital Pharmacology 2019; 6(2): 774-784.
  
  
  8. Stefanović N, Veličković-Radovanović R, Catić-Djordjević A, Damnjanović I, Dinić K, Mitić B, Jevtović-Stoimenov T, Bašić J, Despotović M, Cvetković T. Interindividual and intraindividual pharmacokinetic variability of tacrolimus within the first year after renal transplantation: effect of CYP3A5 gene polymorphism. Acta Medica Medianae 2019; 58(1): 93-101.
  
  
  9. Stefanović N, Cvetković T, Dinić K, Mitić B, Paunović G, Damnjanović I, Catić-Đorđević A, Veličković-Radovanović R. Influence of Different Formulations of  Tacrolimus on Dosage Regimen and Drug Exposure Within the First Year After Kidney Transplantation. Hospital Pharmacology 2019; 6(2): 774-784.
  
  
  10. Damnjanović I, Kocić G, Najman S, Stojanović S, Tomović K, Ilić B, Veljković A, Šmelcerović A. Molecular mechanisms of potential synergistic effect of  ketoprofen and meloxicam with conventional cytostatics in human cervix cancer cell line. Acta Medica Medianae 2018; 57(4): 52-59.
  
  
  11. Damnjanović I, Kitić D, Stefanović N, Zlatković–Guberinić S, Catić–Đorđević A, Veličković–Radovanović R. The use of herbal dietary supplements in diabetic patients: role of healthcare professionals. Acta Medica Medianae. Doi broj: 10.5633/amm.2017.0404.
  
  
  12. Veličković-Radovanović R, Stefanović N, Damnjanović I, Petrović J, Mitić R, Kocić B, Antić S, Dinić M,  Catić-Đorđević A.  The Analysis of Antibiotic Consumption and Bacterial Resistance in Tertiary Healthcare Centre Niš. Hospital Pharmacology 2016; 3(1):341-347.
  
  
  13. Veličković-Radovanović R, Stefanović N, Damnjanović I, Petrović J, Mitić R, Lilić R, Kocić B, Antić S, Dinić M, Catić-Đorđević A. Monitoring of the cephalosporins consumption in the tertiary care hospital. Acta Medica Medianae 2015; 54(2): 31-36.
  
  
  14. Damnjanović I, Velickovic - Radovanovic R, Kocic R, Zlatkovic-Guberinic, Sokolovic D, Djindjic, N, Conic I. Uticaj beta blokatora na insulinsku rezistenciju kod pacijenata sa dijabetes melitusom tip 2. Acta Medica Medianae 2011;50(4):23-28.
  
  
  15. Damnjanovic I, Kitic D, Zlatkovic-Guberinic S, Milosavljevic J, Conic I. Savremeni aspekti upotrebe Valerianae officinalis. Acta Medica Medianae 2010;49(3):65-70.
  
  
  16. Damnjanovic I,Velickovic - Radovanovic R, Catic - Djordjevic A, Kocic R, Ciric V, Conic I, Bjelakovic LJ. Farmakokineticko i farmakodinamicko modeliranje bazalnih insulin i analoga. Acta Medica Medianae 2009;48(1):15-19.
  
  
  17. Damnjanovic Z, Nagorni A, Kocic G, Blagojevic Z, Mančić Dj, Damnjanovic I. Praćenje biohemijskih parametara holestaze I intenziteta oksidativnog stresa kod bolesnika sa holedoholitijazom. Acta Medica Medianae 2008; 47(3): 21-27.
  
  
  18. Conic I, Stanojevic Z, Dedović I, Lilic G. Anksioznost i depresivnost kod bolesnica sa karcinomom grlića materice pre operativnog lečenja. Acta Medica Medianae 2008;47(2): 49 -53.
  
  
• Radovi na naučnim skupovima međunarodnog značaja:
  
  
  1. Damnjanovic I, Velickovic-Radovanovic R, Stefanovic N, Catic – Djordjevic A, Damnjanovic Z, Milic D. Self-medication frequency in the patient with chronic venous diseases. 10^th Balkan Venous Forum, 1 & 2 November 2019, Thessaloniki, Greece.
  
  
  2. Catić-Đorđević A,  Veličković-Radovanović R, Spasić A,   Mitić B, Paunović G, Damnjanović I.  Gender-related differences in gastrointestinal  adverse  effects after mycophenolic acid therapy in renal transplant recipients. 14^th Serbian congress of farmacologists and 4^th Serbian congress of clinical pharmacology with international participation Novi Sad 18-21 September 2019, Abstract book: 81-81.
  
  
  3. Damnjanović I, Stojanović D, Kocić G, Najman S, Stojanović S, Pešić S.The role of alpha –lipoic acid in cancer prevention and treatment. 52^nd Days of preventive medicine, September 25^th-28^th, 2018, Niš, Serbia, Abstract book: 146.
  
  
  4. Catić-Dorđević A Stefanović N, Damnjanović I, Bojanić N, Veličković-Radovanović R. Medication review as a tool to optimize prescribing in residential home center for elderly. Archives of the Balkan Medical Union (Abstracts from 35th Balkan medical week; September 25^th-27^th, 2018,  Athens, Greece) 2018;  53(1): 155-6.
  
  
  5.  Damnjanović I, Kocić G, Najman S, Stojanović S, Veljković A, Pešić S. The role and significance of mitochondrial markers of apoptosis in colon cancer treatment. Archives of pharmacy, special issue (Abstracts from VII Serbian congress of pharmacy with internacional participations, October 10^th-14^th, 2018, Belgrade, Serbia.) 2018, 2(68): 294.
  
  
  6. Damnjanović I, Catić Đorđević A, Stefanović N, Zlatković Guberinić S, Milošević D, Veličković Radovanović R. Influence of health care professionals in preventing medication errors. 50. Days of preventive medicine, September 22^th-25^th_, Niš 2016, Abstract book: 234.
  
  
  7. Damnjanović I, Kitic D, Stefanovic N, Zlatkovic-Guberinić, Catic-Djordjevic A, Velicković-Radovanović R. Use  of  herbal  dietary  supplements  in  patients  with diabetes  mellitus type 2. 49. Days of preventive medicine, September 22^th-25^th, 2015, Niš, Serbia,Abstract book: 54.
  
  
  8. Damnjanovic I, Kocic G, Najman S, Stojanovic S, Veljkovic A, Pešic S. NF-kB as potential chemopreventive target of meloxicam in the treatment of colon cancer cells in vitro. VI Serbian congress of pharmacy, October 15^th-19^th, 2014, Belgrade, Serbia, Abstract book: 256-257.
  
  
  9. Catić-Đorđević A, Stefanović N, Dimitrijević M, Damnjanović I, Ninčić J, Veličković-Radovanović R. The role of clinical pharmacist in community pharmacy. VI Serbian congress of pharmacy, October 15^th-19^th, 2014, Belgrade, Serbia,Abstract book: 231-232.
  
  
  10. Catic-Djordjevic A , Stefanovic N, Dimitrijevic M, Damnjanovic I, Pavlovic S, Velickovic-Radovanovic R. Safety and potential risk of self-medication in Nis region. 48. Days of preventive medicine, September  23^th-26^th, 2014, Niš, Serbia, Abstract book:255.
  
  
• Radovi na domaćim naučnim skupovima:
  
  
  1. Danković K, Stefanović N, Damnjanović I, Catić-Đorđević A, Veličković-Radovanović R, Cvetković T. Potential significance of Bradykinin 2 receptor and/or angiotensin‐converting enzyme genotyping in kidney transplant recipients. Drugi naučni simpozijum saveza farmaceutskih udruženja Srbije sa međunarodnim učešćem, 28. oktobar, 2021, Beograd, Srbija (Sažetak štampan u Arh. farm 2021; 71: S110 – S113) 
  
  
  2. Stefanović N, Danković K, Damnjanović I, Catić-Đorđević A, Cvetković T, Veličković-Radovanović R. Significance of simultaneous analysis of CYP3A5 genotype, concentration/dose ratio and intraindividual variability of tacrolimus in kidney transplant recipients. Drugi naučni simpozijum saveza farmaceutskih udruženja Srbije sa međunarodnim učešćem, 28. oktobar, 2021, Beograd, Srbija (Sažetak štampan u Arh. farm. 2021; 71: S116 – S117) 
  
  
  3. Damnjanović I, Stefanović N, Damnjanović Z,Catić-Đorđević A, Veličković-Radovanović R. Pharmacotherapy and risk factors of intermittent claudication in patients with peripheral arterial disease. Drugi naučni simpozijum saveza farmaceutskih udruženja Srbije sa međunarodnim učešćem, 28. oktobar, 2021, Beograd, Srbija (Sažetak štampan u Arh. farm. 2021; 71: S108 – S109)